NEWS
Jun 23, 2022
Actimed Therapeutics to present on development of its lead asset in treatment of cancer cachexia at the Society on Sarcopenia, Cachexia and Wasting Disorders
May 4, 2022
Actimed Therapeutics secures significant new patent, extending IP coverage of its lead compound for use in key indication
Management Team and Board